BIOMAT Database Logo BIOMAT Database Logo

The effect of aspirin on the pharmacokinetics of sulfinpyrazone in man. 1983

M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001241 Aspirin The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5) Acetylsalicylic Acid,2-(Acetyloxy)benzoic Acid,Acetysal,Acylpyrin,Aloxiprimum,Colfarit,Dispril,Easprin,Ecotrin,Endosprin,Magnecyl,Micristin,Polopirin,Polopiryna,Solprin,Solupsan,Zorprin,Acid, Acetylsalicylic
D013442 Sulfinpyrazone A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties. Sulfoxyphenylpyrazolidin,Anturan,Anturane,Apo-Sulfinpyrazone,Nu-Sulfinpyrazone,Sulphinpyrazone,Apo Sulfinpyrazone,Nu Sulfinpyrazone

Related Publications

M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man.
December 1975, European journal of clinical pharmacology,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
The effect of sulfinpyrazone on platelet deposition on Dacron vascular grafts in man.
March 1985, American heart journal,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
THE EFFECT OF SULFINPYRAZONE (ANTURAN) ON PLATELET ECONOMY AND BLOOD COAGULATION IN MAN.
April 1965, Canadian Medical Association journal,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
Sulfinpyrazone and aspirin-induced asthma.
September 1980, The New England journal of medicine,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
[Sulfinpyrazone and aspirin in experimental microthrombosis].
April 1981, Archivos de farmacologia y toxicologia,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
Effects of concomitant aspirin administration on the pharmacokinetics of indomethacin in man.
December 1978, Journal of pharmacokinetics and biopharmaceutics,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
Effects of aspirin and sulfinpyrazone on platelet prostaglandin synthesis.
January 1977, Advances in experimental medicine and biology,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
New metabolites of sulfinpyrazone in man.
January 1980, Arzneimittel-Forschung,
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
Effect of aspirin on suprathreshold pain in man.
August 1958, Science (New York, N.Y.),
M R Buchanan, and L Endrenyi, and A R Giles, and J Rosenfeld
The Canadian trial of aspirin and sulfinpyrazone in threatened stroke.
October 1978, The New England journal of medicine,
Copied contents to your clipboard!